2018
DOI: 10.1097/bor.0000000000000458
|View full text |Cite
|
Sign up to set email alerts
|

A review of current management of vasculo-Behcet's

Abstract: Behcet disease patients are at risk of developing multiple vascular complications including thrombosis and aneurysms. Treatment should focus on reducing inflammation; and the role of anticoagulation is still debatable.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 50 publications
0
27
0
Order By: Relevance
“…A skin biopsy also revealed histological findings of necrotizing vasculitis. Dilatation of the SMA and its jejunal branch led to a diagnosis of vasculo-BD (10).…”
Section: Case Reportmentioning
confidence: 99%
See 1 more Smart Citation
“…A skin biopsy also revealed histological findings of necrotizing vasculitis. Dilatation of the SMA and its jejunal branch led to a diagnosis of vasculo-BD (10).…”
Section: Case Reportmentioning
confidence: 99%
“…The arterial complications are commonly isolated, but can be multiple (8), with the abdominal aorta as the most common site (9). BD lesions of superior mesenteric artery (SMA) are very rare, but can result in arterial rupture and death (5,10). Although the general epidemiological features of vascular manifestations in patients with BD have been reported (11), the features of SMA lesions have not fully been summarized.…”
Section: Introductionmentioning
confidence: 99%
“…Conceptually, in a genetically susceptible host, Behcet’s vasculitis causes endothelial damage that induces a hypercoagulable state augmented by increased platelet aggregation and impaired fibrinolysis 8. Furthermore, T-cell overproduction of proinflammatory interleukin (IL)-21 and IL-17A intensifies the inflammatory cascade, with other ILs and TNF playing a role 8.…”
Section: Discussionmentioning
confidence: 99%
“…Conceptually, in a genetically susceptible host, Behcet’s vasculitis causes endothelial damage that induces a hypercoagulable state augmented by increased platelet aggregation and impaired fibrinolysis 8. Furthermore, T-cell overproduction of proinflammatory interleukin (IL)-21 and IL-17A intensifies the inflammatory cascade, with other ILs and TNF playing a role 8. Arterial aneurysmal formation in Behcet’s is not atherosclerotic but due to arterial wall inflammation causing damage to the media, fibrosis, obliteration of the vasa vasorum and, ultimately, wall dilation with pseudoaneurysm formation 9.…”
Section: Discussionmentioning
confidence: 99%
“…The management of BD depends on whether there are self-limiting manifestations or serious organ involvement, and should be individualised according to age, gender and type. 12,13 In systemic severe disease, intravenous pulse corticosteroids followed by daily oral doses, azathioprine, cyclophosphamide, cyclosporine-A, methotrexate, mycophenolate mofetil, tacrolimus, interferon (IFN)-α or TNF-α inhibitors (etanercept, infliximab) can be chosen. 12 A new oral inhibitor of phosphodiesterase-4, apremilast, has been studied in patients without major organ involvement and demonstrated a complete response in significantly more patients.…”
Section: Treatment Optionsmentioning
confidence: 99%